Chitranshi is a Team Leader in the Chemicals & Materials (CnM) and Energy & Power (EnP) domains, with 6+ years of experience in market research. She leads and mentors teams to deliver cross-domain projects that equip clients with actionable insights and growth strategies.
She is skilled in market estimation, forecasting, competitive benchmarking, and both primary & secondary research, enabling her to turn complex data into decision-ready insights. An engineer and MBA professional, she combines technical expertise with strategic acumen to solve dynamic market challenges.
Chitranshi has successfully managed projects that support market entry, investment planning, and competitive positioning, while building strong client relationships. Certified in Advanced Excel & Power BI she leverages data-driven approaches to ensure accuracy, clarity, and impactful outcomes.
The secondary research process involved comprehensive analysis of regulatory databases, pharmacopeial standards, peer-reviewed pharmaceutical journals, clinical publications, and authoritative health and food safety organizations. Key sources included the US Food & Drug Administration (FDA), European Medicines Agency (EMA), US Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI/PubMed), World Health Organization (WHO) Essential Medicines List, Centers for Disease Control and Prevention (CDC), US Department of Agriculture (USDA) FoodData Central, European Food Safety Authority (EFSA), Food Standards Australia New Zealand (FSANZ), China National Medical Products Administration (NMPA), Pharmaceuticals and Medical Devices Agency (PMDA) Japan, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), American Society of Health-System Pharmacists (ASHP), National Health Service (NHS) UK, Health Canada, Therapeutic Goods Administration (TGA) Australia, and national health ministry reports and pharmacovigilance databases from key markets.
Pharmacopeial monograph updates, clinical efficacy studies, adverse event reports, nutritional fortification guidelines, dietary reference intakes, manufacturing standards, and competitive landscape analysis for calcium gluconate across pharmaceutical, nutritional, and food additive applications were gathered from these sources.
Primary Research
In order to gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research process. CEOs, VPs of Manufacturing, heads of regulatory affairs, directors of quality control, and commercial directors from manufacturers of calcium gluconate API, makers of finished dosage forms, and contract manufacturers of pharmaceuticals and nutraceuticals were examples of supply-side sources. Chief pharmacists, clinical nutrition specialists, hospital procurement managers, food and beverage R&D directors, and procurement leads from hospitals, clinical nutrition service providers, pharmaceutical distributors, and food fortification firms were examples of demand-side sources. Primary research acquired information on formulation adoption patterns, price dynamics, raw material sourcing strategies, and regulatory compliance needs. It also confirmed capacity expansion timeframes and validated market segmentation across pharmaceutical grade and food grade categories.
Primary Respondent Breakdown:
By Designation: C-level Primaries (32%), Director Level (31%), Others (37%)
By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)
Market Size Estimation
Revenue mapping and volume analysis across food-grade and pharmaceutical segments were used to determine the global market valuation. The methodology comprised:
Finding more than forty major producers and API providers in North America, Europe, Asia-Pacific, and Latin America
Product mapping for food fortification grades, oral tablets and capsules, injectable solutions, and clinical nutrition formulations
Analysis of annual sales for calcium gluconate product portfolios, both reported and modeled
coverage of producers accounting for 65–70% of the world market in 2024
Extrapolation of segment-specific valuations for pharmaceutical and food-grade applications utilizing top-down (manufacturer revenue validation) and bottom-up (production volume × ASP by grade and location) methods
無料サンプルをダウンロード
このレポートの無料サンプルを受け取るには、以下のフォームにご記入ください
この市場に関する地域レポートはありません。
この市場に関する国別レポートはありません。
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah MalgeriCo-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph AguayoSales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkampAccount and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria DoddProgram Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan ChoiSenior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile").
In general the report is well structured. Thanks very much for your efforts.”
Mark IrwinManagement Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob KooikerGroup Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif MorogluStrategy & Business Development Director